The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
New offshoring locations
Ireland, Netherlands
430 - 450 jobs Number of planned job losses
Announcement Date
3 February 2006
Employment effect (start)
1 February 2006
Foreseen end date
28 February 2007
Description
Fournier, a manufacturer of basic pharmaceutical products owned by the Belgian group Solvay, announced on 3 February 2006 that it would cut 400 jobs in France. On 23 October 2006 the company announced the cuts of further 30 to 50 jobs in France before the end of February 2007. Certain activities could be transferred to Ireland and the Netherlands. The R&D site in Dijon is to remain in any case. Fournier currently employs 880 people.
Sources
23 October 2006: Les Echos
Citation
Eurofound (2006), Fournier, Offshoring/Delocalisation in France, factsheet number 64288, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/64288.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
